Prevalence and clinical characteristics of Charles Bonnet syndrome in Madrid, Spain

Purpose: Charles Bonnet syndrome (CBS) is a condition characterized by development of visual hallucinations in patients with no cognitive impairment and significant loss of vision mainly caused by age-related macular degeneration (AMD) or glaucoma. Methods: This was a study of prevalence and charact...

Descripción completa

Detalles Bibliográficos
Autores: Santos Bueso, Enrique Miguel, Sáenz Francés, Federico, Serrador García, Mercedes, Porta Etessam, Mariano Jesús, Martínez De La Casa Fernández-Borrella, José María, García Feijoo, Julián, García Sánchez, Julián
Tipo de recurso: artículo
Fecha de publicación:2014
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/35443
Acceso en línea:https://hdl.handle.net/20.500.14352/35443
Access Level:acceso abierto
Palabra clave:616:617.7
617.736-007
617.7-007.681
Age-related macular degeneration
Charles Bonnet syndrome
Glaucoma
Low vision
Visual hallucinations
Neurociencias (Medicina)
Oftalmología
2490 Neurociencias
3201.09 Oftalmología
Descripción
Sumario:Purpose: Charles Bonnet syndrome (CBS) is a condition characterized by development of visual hallucinations in patients with no cognitive impairment and significant loss of vision mainly caused by age-related macular degeneration (AMD) or glaucoma. Methods: This was a study of prevalence and characteristics of CBS diagnosed at the Neuroophthalmic Unit within the Ophthalmology Department of Hospital Clínico San Carlos (HCSC), Madrid, Spain. Results: The CBS prevalence in patients from HCSC Madrid is 0.47%, rising to 15% in patients with low vision. Women over 80 years of age comprised 58.3% of the patients, who mainly had AMD (58.3%). Main characteristics of hallucinations included animals (50%), color (58.3%), moving (75%), 6- to 12-month evolution (50%), three times a day frequency (75%), and 3- to 5-minute duration (50%). Conclusions: Charles Bonnet syndrome is a complex process that must be treated jointly by ophthalmologists, neurologists, and psychiatrists in order to ensure accurate diagnosis and adequate management. New studies are needed in order to improve awareness of clinical manifestation of this condition, the incidence of which is underestimated due to patients' fear of being branded mentally ill, as well as physicians' lack of knowledge about CBS.